Publication Information

{'id': 'https://openalex.org/W2101005463', 'doi': 'https://doi.org/10.1056/nejmc052880', 'title': 'Antibodies Neutralizing Peginterferon Alfa during Retreatment of Hepatitis C', 'display_name': 'Antibodies Neutralizing Peginterferon Alfa during Retreatment of Hepatitis C', 'publication_year': 2006, 'publication_date': '2006-03-22', 'ids': {'openalex': 'https://openalex.org/W2101005463', 'doi': 'https://doi.org/10.1056/nejmc052880', 'mag': '2101005463', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16554542'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1056/nejmc052880', 'pdf_url': 'https://www.nejm.org/doi/pdf/10.1056/NEJMc052880?articleTools=true', 'source': {'id': 'https://openalex.org/S62468778', 'display_name': 'New England Journal of Medicine', 'issn_l': '0028-4793', 'issn': ['0028-4793', '1533-4406'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.nejm.org/doi/pdf/10.1056/NEJMc052880?articleTools=true', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5022452075', 'display_name': 'Annemiek A. van der Eijk', 'orcid': 'https://orcid.org/0000-0002-8918-5536'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Annemiek A. van der Eijk', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006373951', 'display_name': 'Jan Maarten Vrolijk', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jan Maarten Vrolijk', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5004691327', 'display_name': 'Bart L. Haagmans', 'orcid': 'https://orcid.org/0000-0001-6221-2015'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Bart L. Haagmans', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 42, 'citation_normalized_percentile': {'value': 0.969512, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '354', 'issue': '12', 'first_page': '1323', 'last_page': '1324'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10340', 'display_name': 'Hepatitis B Virus Studies', 'score': 0.9922, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10351', 'display_name': 'Liver Disease Diagnosis and Treatment', 'score': 0.9902, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/peginterferon-alfa-2a', 'display_name': 'Peginterferon alfa-2a', 'score': 0.7052635}, {'id': 'https://openalex.org/keywords/hepatitis-c', 'display_name': 'Hepatitis C', 'score': 0.49078187}, {'id': 'https://openalex.org/keywords/interferon-alfa', 'display_name': 'Interferon alfa', 'score': 0.4644437}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.96207756}, {'id': 'https://openalex.org/C2780040827', 'wikidata': 'https://www.wikidata.org/wiki/Q421862', 'display_name': 'Ribavirin', 'level': 4, 'score': 0.8280369}, {'id': 'https://openalex.org/C2777214474', 'wikidata': 'https://www.wikidata.org/wiki/Q147778', 'display_name': 'Cirrhosis', 'level': 2, 'score': 0.7715105}, {'id': 'https://openalex.org/C2778019345', 'wikidata': 'https://www.wikidata.org/wiki/Q1148337', 'display_name': 'Hepatocellular carcinoma', 'level': 2, 'score': 0.7705332}, {'id': 'https://openalex.org/C2776235749', 'wikidata': 'https://www.wikidata.org/wiki/Q420056', 'display_name': 'Peginterferon alfa-2a', 'level': 5, 'score': 0.7052635}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.6517587}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5832455}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.5410657}, {'id': 'https://openalex.org/C2776408679', 'wikidata': 'https://www.wikidata.org/wiki/Q708693', 'display_name': 'Hepatitis C virus', 'level': 3, 'score': 0.53558475}, {'id': 'https://openalex.org/C2776455275', 'wikidata': 'https://www.wikidata.org/wiki/Q154869', 'display_name': 'Hepatitis C', 'level': 2, 'score': 0.49078187}, {'id': 'https://openalex.org/C3020491458', 'wikidata': 'https://www.wikidata.org/wiki/Q131742', 'display_name': 'Chronic hepatitis', 'level': 3, 'score': 0.4823498}, {'id': 'https://openalex.org/C2781228144', 'wikidata': 'https://www.wikidata.org/wiki/Q6046441', 'display_name': 'Interferon alfa', 'level': 4, 'score': 0.4644437}, {'id': 'https://openalex.org/C2776178377', 'wikidata': 'https://www.wikidata.org/wiki/Q188269', 'display_name': 'Interferon', 'level': 2, 'score': 0.44241607}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.38295442}, {'id': 'https://openalex.org/C2909179924', 'wikidata': 'https://www.wikidata.org/wiki/Q6046488', 'display_name': 'Alpha interferon', 'level': 3, 'score': 0.3410956}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.27505785}], 'mesh': [{'descriptor_ui': 'D000906', 'descriptor_name': 'Antibodies', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': True}, {'descriptor_ui': 'D019698', 'descriptor_name': 'Hepatitis C, Chronic', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000906', 'descriptor_name': 'Antibodies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D019698', 'descriptor_name': 'Hepatitis C, Chronic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019698', 'descriptor_name': 'Hepatitis C, Chronic', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077190', 'descriptor_name': 'Interferon alpha-2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011092', 'descriptor_name': 'Polyethylene Glycols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011092', 'descriptor_name': 'Polyethylene Glycols', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D011092', 'descriptor_name': 'Polyethylene Glycols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1056/nejmc052880', 'pdf_url': 'https://www.nejm.org/doi/pdf/10.1056/NEJMc052880?articleTools=true', 'source': {'id': 'https://openalex.org/S62468778', 'display_name': 'New England Journal of Medicine', 'issn_l': '0028-4793', 'issn': ['0028-4793', '1533-4406'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16554542', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1056/nejmc052880', 'pdf_url': 'https://www.nejm.org/doi/pdf/10.1056/NEJMc052880?articleTools=true', 'source': {'id': 'https://openalex.org/S62468778', 'display_name': 'New England Journal of Medicine', 'issn_l': '0028-4793', 'issn': ['0028-4793', '1533-4406'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.85}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 5, 'referenced_works': ['https://openalex.org/W2027545702', 'https://openalex.org/W2075095707', 'https://openalex.org/W2127685726', 'https://openalex.org/W2156574153', 'https://openalex.org/W2332630894'], 'related_works': ['https://openalex.org/W4256732594', 'https://openalex.org/W2887011061', 'https://openalex.org/W2402582295', 'https://openalex.org/W2095505229', 'https://openalex.org/W2053625043', 'https://openalex.org/W2014171438', 'https://openalex.org/W2001433013', 'https://openalex.org/W1986651510', 'https://openalex.org/W197269132', 'https://openalex.org/W1968813785'], 'abstract_inverted_index': {'To': [0], 'the': [1, 93], 'Editor:': [2], 'Peginterferons': [3], 'are': [4], 'widely': [5], 'used': [6], 'to': [7, 35, 66, 81], 'treat': [8], 'chronic': [9, 73], 'hepatitis': [10], 'C': [11], 'virus': [12], '(HCV)': [13], 'infection,': [14], 'an': [15], 'important': [16], 'cause': [17], 'of': [18, 42, 71, 85], 'liver': [19, 57], 'cirrhosis': [20, 58], 'and': [21, 37, 90], 'hepatocellular': [22], 'carcinoma.1–4': [23], 'We': [24, 96], 'describe': [25], 'a': [26, 32, 39, 82], 'patient': [27], 'who': [28], 'did': [29], 'not': [30], 'have': [31], 'virologic': [33], 'response': [34, 80], 'peginterferon': [36, 44, 88], 'had': [38, 47, 77, 78], 'virtual': [40], 'absence': [41], 'circulating': [43], 'alfa-2a': [45], 'but': [46], 'neutralizing': [48], 'antibodies': [49], 'against': [50], 'interferon': [51], 'alfa.': [52], 'A': [53], '38-year-old': [54], 'man': [55], 'with': [56, 87], '(Child–Pugh': [59], 'class': [60], 'A;': [61], 'score,': [62], '5)': [63], 'was': [64], 'referred': [65], 'our': [67], 'hospital': [68], 'for': [69], 'evaluation': [70], 'his': [72], 'HCV': [74], 'infection.': [75], 'He': [76], 'no': [79], '16-week': [83], 'course': [84], 'treatment': [86], 'alfa-2b': [89], 'ribavirin': [91], 'during': [92], 'previous': [94], 'year.': [95], 'enrolled': [97], 'him': [98], '.\xa0.\xa0.': [99]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2101005463', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-12-17T08:25:14.773025', 'created_date': '2016-06-24'}